A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis

Authors:

Abstract
Objective: To explore the relationship between persistence with alendronate therapy and fracture rates in women with postmenopausal osteoporosis.Research design and methods: Claims data from a large US health plan database were used to examine persistence with therapy in postmenopausal women followed for 24 months. Persistence was defined as the time (in days) from the date of first fill to the run-out date of the last prescription with no lapses > 30 days after completion of the previous refill. A persistent cohort (length of persistence ≥ 182 days) and a non-persistent cohort (length of persistence < 182 days) were defined. The number of patients with a fracture claim in each cohort was determined. Cox-proportional hazards regression (HR) analysis was used to determine significant differences in fracture rates between the two cohorts.Results: 4769 patients were followed for 24 months. Patients in the persistent cohort were significantly more likely to receive a treatment (vs. prevention) dose of...

This publication has 39 references indexed in Scilit: